Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROs in Renal Transplant Patients With/Without GI Symptoms
NCT00529269Phase 4Completed
- Sponsor
- Novartis
- Start
- Dec 2006
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mycophenolate sodium in kidney transplant rejection, sponsored by Novartis. Started Dec 2006; status: completed.
02
Drugs
mycophenolate sodium
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00529269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00529269.